In addition, in these individuals the insulin action in the liver, which has some similarities with the insulin action in muscle, is associated with defects in insulin signaling, e.g., PKCε activation, reductions in insulin-stimulated insulin receptor substrate-2 (IRS-2) tyrosine phosphorylation, in the state of hepatic steatosis. The gene discussed is IRS2; the disease is Hepatic steatosis.